KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - AccuredRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Twist Bioscience (TWST) Retained Earnings (2018 - 2025)

Twist Bioscience (TWST) has disclosed Retained Earnings for 8 consecutive years, with -$1.4 billion as the latest value for Q4 2025.

  • Quarterly Retained Earnings fell 6.01% to -$1.4 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$1.4 billion through Dec 2025, down 6.01% year-over-year, with the annual reading at -$1.3 billion for FY2025, 252692.72% down from the prior year.
  • Retained Earnings for Q4 2025 was -$1.4 billion at Twist Bioscience, down from -$1.3 billion in the prior quarter.
  • The five-year high for Retained Earnings was $428000.0 in Q2 2021, with the low at -$1.4 billion in Q4 2025.
  • Average Retained Earnings over 5 years is -$634.7 million, with a median of -$716.7 million recorded in 2021.
  • The sharpest move saw Retained Earnings skyrocketed 123.37% in 2023, then crashed 1010624.32% in 2024.
  • Over 5 years, Retained Earnings stood at -$656.1 million in 2021, then tumbled by 32.64% to -$870.2 million in 2022, then decreased by 23.67% to -$1.1 billion in 2023, then decreased by 18.33% to -$1.3 billion in 2024, then decreased by 6.01% to -$1.4 billion in 2025.
  • According to Business Quant data, Retained Earnings over the past three periods came in at -$1.4 billion, -$1.3 billion, and -$1.3 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.